Chronic hepatitis B and C cause cirrhosis and liver cancer, and are major causes of death throughout sub-Saharan Africa and Asia. Advances in the diagnosis and management of these chronic viral infections are beginning to impact patient outcomes in low and middle income countries. In this session current hepatitis global guidelines will be discussed, as well as practical issues and new solutions for hepatitis care in resource-limited settings.